Literature DB >> 6823029

Complications of intravenous phenytoin for acute treatment of seizures. Recommendations for usage.

M P Earnest, J A Marx, L R Drury.   

Abstract

Intravenous (IV) phenytoin sodium in small volumes of normal saline was administered in a municipal hospital emergency department for treatment of convulsions in 200 patients. A total of 72 complications developed in 51 patients. Twenty-nine complications were burning pain at the IV site, and 36 were related to excessive total dose of phenytoin and resultant drug intoxication. Seven other patients had cardiovascular complications, including hypotension and arrhythmias. These seven complications were related to high concentrations of drug administered at a rapid rate. Both the IV and cardiovascular complications promptly resolved when the IV rate was slowed or temporarily stopped. No patient died, and none was hospitalized because of a complication. The authors propose specific guidelines for the safe administration of IV phenytoin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6823029

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  23 in total

1.  IV administration of phenytoin.

Authors:  W G Byerly; M W Horton
Journal:  J Gen Intern Med       Date:  1990 Sep-Oct       Impact factor: 5.128

2.  Dr watson responds.

Authors:  C Watson
Journal:  West J Med       Date:  1992-05

Review 3.  Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures.

Authors:  James H Fischer; Tejal V Patel; Patricia A Fischer
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 4.  Fosphenytoin and phenytoin in patients with status epilepticus: improved tolerability versus increased costs.

Authors:  J C DeToledo; R E Ramsay
Journal:  Drug Saf       Date:  2000-06       Impact factor: 5.606

Review 5.  Clinical features and management of poisoning due to phenytoin.

Authors:  J R Larsen; L S Larsen
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jul-Aug

6.  Aplastic anaemia induced by intravenous phenytoin and lidocaine administration.

Authors:  S Tomita; T Kurokawa; K Ueda; S Higuchi
Journal:  Eur J Pediatr       Date:  1985-07       Impact factor: 3.183

7.  Intravenous phenytoin loading in patients after neurosurgery and in status epilepticus. A population pharmacokinetic study.

Authors:  S Vozeh; T Uematsu; L Aarons; P Maitre; H Landolt; O Gratzl
Journal:  Clin Pharmacokinet       Date:  1988-02       Impact factor: 6.447

Review 8.  Purple Glove Syndrome after Phenytoin or Fosphenytoin Administration: Review of Reported Cases and Recommendations for Prevention.

Authors:  Lyudmila A Garbovsky; Byron C Drumheller; Jeanmarie Perrone
Journal:  J Med Toxicol       Date:  2015-12

9.  Rapid in vitro conversion of fosphenytoin into phenytoin in sera of patients with liver disease: role of alkaline phosphatase.

Authors:  A Dasgupta; E Schlette
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

10.  Bioavailability of intravenous fosphenytoin sodium in healthy Japanese volunteers.

Authors:  Yushi Inoue; Naotaka Usui; Tadayuki Hiroki; Kenji Shimizu; Susumu Kobayashi; Shigeki Shimasaki
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2012-09-12       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.